Concepedia

Barry A. Rosenzweig

BA

Statistics

Publications

24

Citations

3.3K

H-Index

18

Active since

1990

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

National Center for Toxicological Research

Harvard University

Illumina (United States)

Barry A. Rosenzweig is an author at Center for Drug Evaluation and Research specializing in medicine, physiology, and pharmacology.

Top concepts

Publications per year

1990–2022

24

Publications

24

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

Leming Shi, Leming Shi, Laura Reid et al. · Nature Biotechnology · 2006 · 2.2K citations

, , +14

Comparison of Kidney Injury Molecule-1 and Other Nephrotoxicity Biomarkers in Urine and Kidney Following Acute Exposure to Gentamicin, Mercury, and Chromium

Yuzhao Zhou, Vishal S. Vaidya, Ronald P. Brown et al. · Toxicological Sciences · 2007 · 296 citations · Full text

Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation

Andrés M. Rubiano, Amruta Indapurkar, Ryosuke Yokosawa et al. · Clinical and Translational Science · 2020 · 89 citations · Full text

Characterization of the effect of sample quality on high density oligonucleotide microarray data using progressively degraded rat liver RNA

Karol L. Thompson, P. Scott Pine, Barry A. Rosenzweig et al. · BMC Biotechnology · 2007 · 87 citations · Full text

Dye bias correction in dual-labeled cDNA microarray gene expression measurements.

Barry A. Rosenzweig, P. Scott Pine, Olen E. Domon et al. · Environmental Health Perspectives · 2004 · 76 citations · Full text

, , +16

Rows per page

1–5 of 24